Phase 1 Trial to Protect the Brains of Infants with Congenital Heart Disease During & After Surgery

A phase 1 trial at Children's National Hospital studies the use of mesenchymal stromal cells (MSCs) as a potential protection for the brains of infants undergoing cardiac surgery. This is the first study to infuse these MSCs via the cardiopulmonary bypass, or heart-lung machine.

For more information about this new treatment, contact the clinical research team:
- Gil Wernovsky, M.D. - https://tinyurl.com/u1mj5nqf
- Shriprasad Deshpande, M.D. - https://tinyurl.com/36yl3app
- Maria Fortiz - mffortiz@childrensnational.org
- Phone: 202-476-4225